(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ROLECA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ROLECA

ST13

US500000079343685

Class

3, 5

Filing

79343685

Registration

7123498

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

04/27/2024

Classification

Registered

Trademark type

Word

Nice classes

3, 5

Filing date

02/24/2022

Registration date

08/01/2023

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/01/2023

Last transaction

08/01/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

DE

Examiner

BAKER,JORDAN A

Law office

O30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Medicocensus GmbH
Mediconomics GmbH

Representatives

Robert S. Broder Collard & Roe, P.C.

Technical classification

Nice Classes

Class 3Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Perfumeryessential oilscosmeticshair lotions; skin soap; dentifrices

Class 5

Pharmaceuticalveterinary and sanitary preparationspreparations for treatment of dyspeptic conditions and obstipation; dietetic substances adapted for medical usedietetic foods adapted for medical usefood for babies; plasters for medical purposesmaterials for dressingsmedical dressings; disinfectants; preparations for destroying noxious animals; fungicidesherbicides

Publications

History of USPTO decisions and trademark events.

27 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/27/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/27/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

11/02/2023

FIMP

FINAL DISPOSITION PROCESSED

11/01/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/01/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/01/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

08/01/2023

GPNX

NOTIFICATION PROCESSED BY IB

05/17/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/16/2023

PUBO

PUBLISHED FOR OPPOSITION

05/16/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/26/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/26/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/26/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/10/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/05/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/05/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/05/2023

RFNT

REFUSAL PROCESSED BY IB

02/28/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/03/2023

RFRR

REFUSAL PROCESSED BY MPU

02/03/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/09/2022

CNRT

NON-FINAL ACTION WRITTEN

12/08/2022

DOCK

ASSIGNED TO EXAMINER

12/08/2022

CHLD

CHANGE OF OWNER RECEIVED FROM IB

10/14/2022

MAFR

APPLICATION FILING RECEIPT MAILED

07/05/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/01/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/30/2022

Continuous trademark protection

Get notified about every new filing that threatens ROLECA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.